
In more than 256,000 adults with prediabetes and obesity, GLP-1s were linked to better blood sugar and heart outcomes than metformin, according to a study presented at the American Heart Association (AHA) Scientific Sessions 2026.
Anaheim, CA-The largest trial of cholesterol-lowering therapy ever conducted extends the current indications for statin therapy, reported Rory Collins, MD.






